Vincerx Inc News - VINC | ADVFN

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Vincerx Inc (VINC)

0.187

-0.0108

(-5.46%)

Closed December 24 4:00PM

Delayed by 15 minutes

0.1853

-0.0017

( -0.91% )

Pre Market: 6:48AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943

PALO ALTO, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical...

Form 8-K - Current report

Form 8-K - Current report

Vincerx Pharma Reports Third Quarter 2024 Financial Results

Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123...

Form PRE 14A - Other preliminary proxy statements

Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates

VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1...

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC TO-I - Tender offer statement by Issuer

1
Next

georgie18

georgie18 2 weeks ago

VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...

georgie18

georgie18 3 weeks ago

VINC...2954...🥳...Trying to Reverse here to the Upside...

tw0122

tw0122 3 months ago

VINC .84 + 20% …05:05 PM EDT, 10/07/2024 (MT Newswires) -- Vincerx Pharma (VINC) said its VIP943 leukemia drug showed "promising safety and tolerability," achieving two complete responses to date in a phase 1 dose-escalation study

The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.

Another data update is expected by the end of the year, the company said.

In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to "champion its future development" in order to focus on VIP943.

Vincerx expects a cash runway into early 2025.

Shares of the company jumped 15% in after-hours activity.

Price: 0.8000, Change: +0.10, Percent Change: +

Laster

Laster 8 months ago

What a cluster this stock has become.
Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
Can’t believe they didn’t try to do the financing when it was trading above $5.

RAlbert

RAlbert 8 months ago

Tomorrow will be $1.50

RAlbert

RAlbert 9 months ago

No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life

RAlbert

RAlbert 9 months ago

Blood bath. I should have waited one more day.

Monksdream

Monksdream 9 months ago

Somebody knows something you don’t

RAlbert

RAlbert 9 months ago

I don’t find the price and volume the capital raise is. Am I missing anything here?

Monksdream

Monksdream 9 months ago

Check for SEC filings

RAlbert

RAlbert 9 months ago

Is the capital raise 80% discounted to yesterday price? Insane

Monksdream

Monksdream 9 months ago

Check for a capital raise which means dilution

RAlbert

RAlbert 9 months ago

Wonder why there is a steep fall in price when the results are not negative.

RAlbert

RAlbert 9 months ago

Wonder why there is a steep fall in price when the results are not negative.

Monksdream

Monksdream 9 months ago

VINC 10Q due 4/3

Monksdream

Monksdream 9 months ago

VINC 10Q due 3/25
Next day settlement 5/28 per SEC mandate

Monksdream

Monksdream 10 months ago

VINC new 52.week hi

Monksdream

Monksdream 10 months ago

VINC new 52 week high

Monksdream

Monksdream 10 months ago

VINC in the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc

Tom turtles

Tom turtles 10 months ago

Very nice surprise...🆙⬆️

Monksdream

Monksdream 10 months ago

VINC new 52 week high

glenn1919

glenn1919 10 months ago

VINC..................................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783

Awl416

Awl416 10 months ago

160k wall getting gobbled up

Awl416

Awl416 10 months ago

Another leg. Damn

Awl416

Awl416 10 months ago

Who’s poking it?

Monksdream

Monksdream 10 months ago

make it happen

make it happen 12 months ago

It's deficient. Failed to meet NASDAQs listing requirements. I'm expecting a reverse split in the future.

alchemytrader

alchemytrader 12 months ago

Monksdream

Monksdream 1 year ago

AstraZeneca PLC ADRhedged

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions